A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in ...

A study has found that glucagon-like peptide-1 (GLP-1) class obesity treatments, such as ‘Wegovy,’ may slow the rate of alcohol absorption. By delaying alcohol absorption, they reportedly reduce ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Because GLP-1 agonists seem to reduce patients’ desire for food, it isn’t surprising that they might also shrink or even ...

A Pacific Northwest program that helps people overcome drug and alcohol addiction is this month's One Class at a Time recipient of $1,000 from Mid Oregon Credit Union. Bola Gbadebo visited the Central ...

Weight-loss drugs like Wegovy and Zepbound are transforming the health of millions of people—and a new study hints that even more could benefit from the drugs’ other effects on the body. A study ...

A small study found that drugs like Ozempic, Wegovy, and Mounjaro change the way the body processes alcohol, making it less ...

In the late 19th century, opiates and cocaine were commonly prescribed by physicians for a wide range of ailments. Patent medicines frequently included morphine, laudanum, cocaine and heroin as key ...